{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:06:03Z","timestamp":1787501163218,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether the presence of psoriasis influences the clinical expression, disease activity and disease burden in both axial and peripheral phenotypes of spondyloarthritis (SpA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients from the Spanish REGISPONSER registry classified as having SpA according to the ESSG criteria were included. Patients were classified as psoriatic or non-psoriatic depending on the presence of cutaneous or nail psoriasis; thereafter, they were classified as having either axial [presence of radiographic sacroiliitis OR inflammatory back pain (IBP)] or peripheral phenotype (absence of radiographic sacroiliitis AND absence of IBP AND presence of peripheral involvement). Pair-wise univariate and multivariate analyses among the four groups (psoriatic\/non-psoriatic axial phenotypes and psoriatic\/non-psoriatic peripheral phenotypes) were performed with adjustment for treatment intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2296 patients were included in the analysis. Among patients with axial phenotype, psoriasis was independently associated (P\u2009&amp;lt;\u20090.05) with HLA-B27+ [odds ratio (OR) 0.27], uveitis (OR 0.46), synovitis (ever) (OR 2.59), dactylitis (OR 2.78) and the use of conventional synthetic DMARDs (csDMARDs) (OR 1.47) in comparison with non-psoriatic patients. Among patients with peripheral phenotype and adjusting for csDMARD intake, psoriasis was independently associated with higher age at disease onset (OR 1.05), HLA-B27+ (OR 0.14) and heel enthesitis (OR 0.22). Higher scores for patient-reported outcomes and greater use of treatment at the time of the study visit were observed in psoriatic patients with either axial or peripheral phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that, among all patients with SpA, psoriasis is associated with differences in clinical expression of SpA, a greater disease burden and increased use of drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa398","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T07:09:29Z","timestamp":1591859369000},"page":"1125-1136","source":"Crossref","is-referenced-by-count":11,"title":["Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry"],"prefix":"10.1093","volume":"60","author":[{"given":"Clementina","family":"L\u00f3pez-Medina","sequence":"first","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"},{"name":"Rheumatology Department, Cochin Hospital from Paris\/INSERM U 1153, Clinical Epidemiology and Biostatistics, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Ortega-Castro","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Carmen","family":"Castro-Villegas","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Font-Ugalde","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M \u00c1ngeles","family":"Puche-Larrubia","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"G\u00f3mez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Arias-de la Rosa","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Barbarroja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Schiotis","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Iuliu Hatieganu University of Medicine and Pharmacy, SCBI, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Collantes-Est\u00e9vez","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, C\u00f3rdoba\/Maimonides Research Institute of Biomedical Medicine from Cordoba (IMIBIC), University of C\u00f3rdoba, C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"2021030705491676200_keaa398-B1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"2021030705491676200_keaa398-B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021030705491676200_keaa398-B3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021030705491676200_keaa398-B4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021030705491676200_keaa398-B5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for medication of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2021030705491676200_keaa398-B6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021030705491676200_keaa398-B7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/rheumatology\/kez457","article-title":"Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?","volume":"59","author":"Feld","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021030705491676200_keaa398-B8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2021030705491676200_keaa398-B9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kem084","article-title":"Disease pattern of spondyloarthropathies in Spain: description of the first registry (REGISPONSER)","volume":"46","author":"Collantes","year":"2007","journal-title":"Rheumatology"},{"key":"2021030705491676200_keaa398-B10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","article-title":"Clinical history as a screening test for ankylosing spondylitis","volume":"237","author":"Calin","year":"1977","journal-title":"JAMA"},{"key":"2021030705491676200_keaa398-B11","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondyilitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garret","year":"1994","journal-title":"J Rheumatol"},{"key":"2021030705491676200_keaa398-B12","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2021030705491676200_keaa398-B13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4067\/S0034-98872014001000007","article-title":"[Evaluation of the SF-12: usefulness of the mental health scale]","volume":"142","author":"Vera-Villarroel","year":"2014","journal-title":"Rev Med Chil"},{"key":"2021030705491676200_keaa398-B14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021030705491676200_keaa398-B15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalence of psoriasis in Spain in the age of biologics","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"2021030705491676200_keaa398-B16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molto","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021030705491676200_keaa398-B17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ard.37.6.504","article-title":"HLA B27 and the genetics of ankylosing spondylitis","volume":"37","author":"Woodrow","year":"1978","journal-title":"Ann Rheum Dis"},{"key":"2021030705491676200_keaa398-B18","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/rheumatology\/kex057","article-title":"Ocular involvement in patients with spondyloarthritis","volume":"56","author":"Bacchiega","year":"2017","journal-title":"Rheumatology (Oxford"},{"key":"2021030705491676200_keaa398-B19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2021030705491676200_keaa398-B20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/CCID.S147236","article-title":"Associations between body mass index and severity of psoriasis","volume":"10","author":"Sobhan","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2021030705491676200_keaa398-B21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"2021030705491676200_keaa398-B22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/art.22290","article-title":"Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondyloarthritides and allied disorders","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021030705491676200_keaa398-B23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"key":"2021030705491676200_keaa398-B24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021030705491676200_keaa398-B25","first-page":"1002","volume-title":"Rheumatology","author":"Wysham","year":"2019"},{"key":"2021030705491676200_keaa398-B26","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1136\/rmdopen-2018-000867","article-title":"Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry","volume":"5","author":"Mease","year":"2019","journal-title":"RMD Open"},{"key":"2021030705491676200_keaa398-B27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/acr.22330","article-title":"Early tumor necrosis factor \u03b1 antagonist therapy in everyday practice for inflammatory back pain suggesting axial sponyloarthritis: results from a prospective multicenter French cohort","volume":"66","author":"Canou\u00ef-Poitrine","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021030705491676200_keaa398-B28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3899\/jrheum.181331","article-title":"Peripheral manifestations in spondyloarthritis and their impact: an ancillary analysis of the ASAS-COMOSPA study","volume":"47","author":"L\u00f3pez-Medina","year":"2020","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/3\/1125\/36434331\/keaa398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/3\/1125\/36434331\/keaa398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:53:19Z","timestamp":1615078399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/3\/1125\/5898387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,28]]},"published-print":{"date-parts":[[2021,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa398","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s00296-025-06021-z","asserted-by":"object"}]},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,8,28]]}}}